Assessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of Varenicline

Схожие документы

• Identification and Characteristics of Time-Related Shifts in Suicide-Related Event Frequency During Smoking Cessation Treatment with Varenicline
  по: Akimoto, Hayato, et al.
  Опубликовано: (2017)
• Onset timing of statin‐induced musculoskeletal adverse events and concomitant drug‐associated shift in onset timing of MAEs
  по: Akimoto, Hayato, et al.
  Опубликовано: (2018)
• Discrepancies between patients’ and pharmacists’ perceptions of the role of community pharmacists as advisors on the use of pharmaceuticals in Japan: A comparison prior to and following revision of the Pharmacists’ Act
  по: Oshima, Shinji, et al.
  Опубликовано: (2019)
• Varenicline is useful for smoking cessation
  по: Cadden, Paul
  Опубликовано: (2007)
• A survey of subcutaneous blood flow in patients with SMID and subcutaneous ceftazidime administration using mentholated warm compresses in healthy subjects
  по: Ebihara, Tsuyoshi, et al.
  Опубликовано: (2016)